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Apoptosis plays a role in the process of tissue damage after myocardial infarction (MI). This study was designed to
investigate the possible effect of cerebrolysin against apoptosis triggered by oxidative cell stress in myocardial
ischemia induced by isoproterenol in rat. Rats were pretreated with cerebrolysin 5 mL/kg intraperitoneally for 7 days
and intoxicated with isoproterenol (ISO, 85 mg/kg, sc) on the last 2 days. Hearts were excised and stained to detect
the infarction size. Serum levels of cardiotoxicity indices as creatine kinase isoenzyme (CK-MB) and troponin I
(cTnI) as well as the cardiac oxidative stress parameters as thiobarbituric acid reactive substances and superoxide
dismutase were estimated. The expression of prodeath gene p53 and antideath gene Bcl-2 was also assessed from the
excised heart tissues. Leakage of cardiac enzymes, elevated oxidative stress markers, and apoptotic indices conﬁrmed
the MI occurring as a consequence of isoproterenol-induced ischemia. Cerebrolysin pretreatment caused signiﬁcant
attenuation of the oxidative stress-induced apoptosis in the ischemic myocardial tissue. These ﬁndings provided an
evidence that cerebrolysin could protect rat myocardium against ischemic insult that was attributed to its antioxidant
as well as its anti-apoptotic properties.
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Introduction
The role of apoptosis in tissue damage after myocardial infarction (MI) has many pathologi-
cal and therapeutic implications (16). Studies in the ventricular myocytes of the hearts of
patients with acute MI have shown that apoptosis plays a role in the process of cell death of
cardiomyocytes (33). Permanent occlusion of a coronary vessel in rats led to apoptotic
changes in the ischemic region, the immediately bordering area, and the remote area from
ischemia region suggesting that apoptosis is the major determinant of infarct size (27).
Apoptosis is a highly regulated process in which several regulatory proteins play a part, and
in which the balance between an arrays of regulatory proteins decides the fate of the cell. The
expression of the two regulatory proteins, Bcl-2 and Bax, has been studied in the hearts of
patients with MI (22). Bcl-2, an apoptosis inhibitor (13), is expressed in cardiomyocytes
surrounding the infarcted areas after the onset of infarction. Bax is a member of the Bcl-2
family that accelerates apoptosis when overexpressed (25). Therefore, the high Bax to Bcl-2
ratio is related to apoptotic cell death in the old infarction (22). One hypothesized that the
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general molecular mediator of hypoxia-induced apoptosis is the tumor suppressor transcrip-
tion factor p53. It is suggested that p53 may induce apoptosis by stimulating the expression of
Bax and/or repression of Bcl-2 expression (23). Increased oxidative stress was also found to
coexist with apoptosis in the rat myocardium after MI (18).
Cerebrolysin is a mixture of peptide fragment preparation, which mimics the action of
neurotrophic factors and has been proved to be neuroprotective in a number of conditions
such as hyperthermia-induced neurotoxicity, Alzheimer’s disease, vascular dementia, trau-
matic brain injury, and stroke (12). Cerebrolysin was shown to exert neuroprotective and
neurotrophic effects in vivo and in vitro. It induces neuron outgrowth and decreases apoptosis
triggered by growth factor withdrawal in cultivated neurons (11). Also, it has been shown to
reduce the effects of oxidative cell stress in animals following cerebral ischemia (9).
The aim of this study was to investigate the effects of cerebrolysin on the apoptotic and




Cerebrolysin (EVER Neuro Pharma GmbH, Austria, ampoule 1 mL). Isoproterenol hydro-
chloride (ISO, Sigma Chemical Co., St. Louis, MO, USA).
Experimental animals
This study was carried out with 48 Sprague-Dawley male rats weighing approximately
150–200 g. They were maintained under standard conditions of temperature 22 ± 2 °C with
regular 12 h light/12 h dark cycle and allowed free access to standard laboratory food and
water. All experimental procedures were performed in accordance with the guidelines of the
Institutional Animal Care and Use Committee of Mansoura University.
Experimental protocols
Rats were randomly divided into four main groups (12 rats for each group):
Group I – Control group: Rats received saline 1-mL/kg body weight intraperitoneally
(IP) for seven successive days.
Group II – Cerebrolysin-treated group: Rats treated with cerebrolysin 5-mL/kg body
weight IP for seven successive days. This dose of cerebrolysin was chosen
because of its antioxidant effect (36).
Group III – Isoproterenol (ISO)-treated group: Rats received saline and were subjected to
myocardial ischemia by ISO treatment in the last two days.
Group IV – Cerebrolysin-+ ISO-treated group: Rats treated with cerebrolysin and were
subjected to myocardial ischemia by ISO treatment.
Induction of myocardial ischemia
The last two groups were submitted to myocardial ischemia on the last two days
(days 6 and 7) via subcutaneous injection of two equal doses of isoproterenol hydro-
chloride (ISO, 85-mg/kg body weight), dissolved in physiological saline spaced 24 h
apart. The ISO injection started 10 min after the usual dose of saline or cerebrolysin. The
dosage used and time sequence were previously determined as offering a combination of
high survival rate, induction of myocardial necrosis in virtually all of the treated rats (35).
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Twenty four hours after the second dose of ISO injection (day 8), the rats were sacriﬁced
with over dose of anesthesia (thiopental sodium 2.5% 60-mg/kg IP) and blood samples
were collected by cardiac puncture. Blood was centrifuged and serum was separated and
stored at −20 °C for measuring the cardiac biomarker. The hearts of each group were
excised immediately, washed with chilled isotonic saline, and randomly divided into two
groups (6 each). The ﬁrst section was for the measurement of myocardial infarct size. The
other section was dissected, homogenized, and kept at −80 °C until further biochemical
assay.
Measurement of myocardial infarct size
Direct triphenyl tetrazolium chloride (TTC) assay was used to determine the myocardial
infarct size according to the method of Lie et al. (19). In brief, the heart was transversely cut
across the left ventricle, and sections of 2–3 mm thick were incubated in 1% TTC solution
prepared in phosphate buffer pH (7.4) for 30 min at 37 °C, following which they were ﬁxed
with 10% formalin. The non-ischemic myocardium and viable ischemic myocardium were
stained red, while the infarcted myocardium appeared pale gray or white. The slices were
photographed on white background using Olympus® digital camera with a ring ﬂash at high
resolution and converted to TIFF. The % infarction in each image was analyzed on Intel®
Core I3®-based computer using VideoTest Morphology® software Russia with a speciﬁc
built-in routine for area and % area measurement.
Assay of cardiac marker enzymes
Serum creatine phosphokinase (CK-MB) activity and troponin I (cTnI) level were measured
as markers for cardiac muscle damage. CK-MB activity was determined spectrophotometri-
cally at 340 nm using commercially available kits (Stanbio Laboratory, Inc., TX, USA). The
levels of cardiac troponin I (cTnI) in serum were estimated spectrophotometrically at 450 nm
using enzyme-linked immunosorbent assay kits (DRG International, Inc., NJ, USA).
Estimation of lipid peroxidation products
Lipid peroxide level in heart was determined as thiobarbituric acid reactive substances
(TBARs) by the methods of Ohkawa et al. (24). The amount of lipid peroxides was measured
as the production of MDA, which in combination with TBA forms a pink chromogen
compound whose absorbance at 532 nm was measured. The result was expressed as nmol/mg
protein.
Estimation of antioxidants’ activity
Myocardial superoxide dismutase (SOD) activity was measured through the inhibition of
nitroblue tetrazolium reduction by O2 generated by the xanthine/xanthine oxidase system.
One SOD activity unit was deﬁned as the enzyme amount causing 50% inhibition in 1-mL
reaction solution per milligram tissue protein and the result was expressed as U/mg protein
(46). The total protein content in myocardium was determined according to Lowery’s
method (20).
Assay of p53 and Bcl-2 expression of rat mRNA in cardiac tissues by total RNA extraction
and Reverse transcription (RT-PCR)
Total RNA extraction: Total RNA was extracted using Vivantis nucleic acid extraction kit
(GF-1 Total RNA extraction kit, Malaysia) according to the manufacturer’s instructions.
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Reverse transcription reaction: Reverse transcriptase-polymerase chain reaction (RT-
PCR) was performed using Maxima First Strand complementary DNA (cDNA) Synthesis Kit
for cDNA synthesis provided (Thermo Scientiﬁc, USA, Cat. No. #K1641) using PTC-200
thermal cycler (MJ Research, Essex, UK). After that, following the protocol instructions the
reaction mixture was incubated for 10 min at 25 °C followed by 15 min at 50 °C and
terminated by heating at 85 °C for 5 min. cDNA products were ampliﬁed by PCR using gene
speciﬁc primers, their sequences were shown in (Table I), purchased from Biosearch
Technologies (South McDowell Blvd, Petaluma, Canada). Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) was used as a housekeeping control gene. Ampliﬁcation was
done using Emerald Amp GT PCRMaster Mix (2X) (Takara, Japan). The PCR condition was
as follows: initial denaturation at 94 °C for 3 min followed by 35 cycles of (a) denaturation at
94 °C for 1 min; (b) annealing at 60 °C for 2 min, 58 °C for 30 s and 55 °C for 30 s for p53,
Bcl-2, and GAPDH, respectively; and (c) extension at 72 °C for 1 min with subsequent
10 min at 72 °C. The reaction products were subjected to 2% agarose gel electrophoresis
stained with ethidium bromide to visualize the bands.
The results were analyzed with Scion Image® release Alpha 4.0.3.2. Software for
windows® which performs bands detection and conversion to peaks. Area under each peak
was calculated in square pixels and used for quantiﬁcation. p53 and Bcl-2 mRNA expression
levels were determined by calculating the ratio between the square pixel values of the target
bands in relation to the control bands of GAPDH. The identity of the ampliﬁcation was
conﬁrmed by the determination of the molecular size on agarose gel electrophoresis with a
100-bp DNA molecular marker (GIBCO).
Statistical analysis
Data were presented as mean ± SEM. Differences among groups within an experiment were
analyzed by the one-way analysis of variance (ANOVA) of data followed by post hoc test of
Tukey’s HSD. A p value of <0.05 was considered signiﬁcant.
Results
None of the rats died in any experimental group over the entire treatment period. Represen-
tative illustrations of infarction size stained with TTC are shown in Fig. 1. Rats intoxicated
with ISO showed a large infarcted unstained area (11.7 ± 1.1%) in comparison to the control
rats. Pretreatment with cerebrolysin caused signiﬁcant reduction of the infarcted size to
1.5 ± 0.1% with the major portion stained positively indicating tissue viability.
Table I. Sequence of all primers used
Gene Primer sequence PCR product size (bp)
p53 F: 5′-TCT GTC ATC TTC CGT CCC TTC TC-3
R: 5′-AAC ACG AAC CTC AAA GCT GTC CCG-3
547 (39)
Bcl-2 F: 5′-CCT GCC CCA AACAAA TAT GAA AAG-3′
R: 5′-TTG ACC ATT TGCCTGAAT GTG TG-3
174 (15)
GAPDH F: 5′-GTC TTC ACC ACC ATG GAG-3′
R: 5′-CGA TGC CAA AGT TGT CAT G-3′
211 (26)
Cerebrolysin and apoptosis in myocardial ischemia 313
Physiology International (Acta Physiologica Hungarica) 103, 2016
ISO administration showed a signiﬁcant increase in the oxidative stress parameters in
the myocardial tissue represented as signiﬁcant rise of the mean levels of TBARs and
decrease in SOD as compared to the control group. Pretreatment with cerebrolysin along with
ISO showed signiﬁcant decrease in the level of TBARs and increase in SOD as compared to
the ISO-treated group (Fig. 2).
ISO-treated group showed signiﬁcant elevation in the serum creatine phosphokinase
(CK-MB) activity and troponin I (cTnI) level as compared to normal control rats. Pretreat-
ment with cerebrolysin showed signiﬁcant decrease in the levels of the cardiac enzymes when
compared to the ISO-treated group (Table II).
RT-PCR analysis of the myocardial tissue showed that administration of ISO caused
signiﬁcant rise in the expression of the apoptotic marker; p53 and signiﬁcant decrease in the
expression of the anti-apoptotic marker; Bcl-2 in comparison to the control group. Pretreat-
ment with cerebrolysin showed signiﬁcant decrease in the p53 and increase in the Bcl-2
expression as compared to the ISO-treated group (Figs 3 and 4).
Discussion
In this study, pretreatment with cerebrolysin (5 mL/kg/d for 7 days) exerts a cardioprotection
in ISO-induced MI in rats.
MI induced by dual injection of ISO (85 mg/kg/d) is a standardized model to study the























Fig. 1. Effect of pretreatment of cerebrolysin (5 mL/kg) on the cardiac infarction size using TTC stain in ISO-treated
rats. Statistical analysis was carried out by one-way ANOVA followed by Tukey’s HSD multiple comparison test.
All values are presented as means of six rats ± SEM. *Indicates signiﬁcant change from control values at p< 0.05.
+Indicates signiﬁcant change from cerebrolysin-treated groups at p< 0.05. $Indicates signiﬁcant change from ISO-
treated groups at p< 0.05
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infarcted area as shown by TTC staining. This ischemic insult was associated with cardiac
damage that results in signiﬁcant leakage of the cardiac enzymes, elevated oxidative stress
markers, and apoptotic indices. It has been deduced that the detrimental action of isoprotere-
nol is mainly due to β-adrenergic stimulation with rapid heart rhythm. Electrical depression
and failure in the globally ischemic heart may contribute to adverse outcomes as asystole and
ventricular ﬁbrillation (7, 41). The observed increased level of serum CK and troponin I in
ISO-treated rats in this study was in consonance with an earlier report (1, 34). Myocardial
ischemia induced by isoproterenol results in deﬁcient oxygen supply that leads to myocardial
cell damage and rupture with the leakage of their enzyme content decreasing their activities in
the heart of rats (21). It was proved that the plasma levels of troponin found in patients with
unstable angina pectoris provide information about the severity of myocardial ischemia that
caused degradation of cellular troponin and release of troponin degradation products in the
circulation (43). The use of cerebrolysin seemed to preserve the functional and structural
integrity and the permeability of the cardiac membrane, and thus restricting the leakage of
these enzymes from the myocardium, as evident from the markedly reduced levels of these
enzymes in cerebrolysin-treated ischemic group when compared to the non-treated ischemic






















Fig. 2. Effect of pretreatment of cerebrolysin (5 mL/kg) on the mean levels of cardiac oxidative stress parameters in
ISO-treated rats. Statistical analysis was carried out by one-way ANOVA followed by Tukey’s HSD multiple
comparison test. All values are presented as means of six rats ± SEM. *Indicates signiﬁcant change from control
values at p< 0.05. +Indicates signiﬁcant change from cerebrolysin-treated groups at p< 0.05. $Indicates signiﬁcant
change from ISO-treated groups at p< 0.05. TBARs= thiobarbituric acid reactive substances; SOD= superoxide
dismutase








CK-MB (U/L) 259.67 ± 22.34 276.56 ±25.78 896.60 ± 5.32*+ 472.11 ± 39.76*+$
Troponin I (ng/mL) 2.55 ± 0.12 2.34 ± 0.10 6.54 ± 0.56*+ 4.44 ± 0.28*+$
Statistical analysis was carried out by one-way ANOVA followed by Tukey’s HSD multiple comparison test. All
values are presented as means of six rats ± SEM
*Indicates signiﬁcant change from control values at p< 0.05
+Indicates signiﬁcant change from cerebrolysin-treated groups at p< 0.05
$Indicates signiﬁcant change from ISO-treated groups at p< 0.05
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The deterioration of the oxidative stress markers in ISO-treated rats observed in this
study (increase in the lipid peroxidation and decrease in the antioxidant activity) were in
keeping with the previous ﬁndings (32). TBARs’ content is considered an indirect marker of
cellular damage degree as it reﬂects the extent of systemic lipid peroxidation. The antioxidant
SOD activity reﬂects the cellular capacity to scavenge oxygen free radicals (31). ISO may
induce myocardial ischemia due to cytosolic Calcium ion (Ca2+) overload (38). The oxidative
stress may be induced by quinone metabolites of ISO, which reacts with oxygen to produce
reactive oxygen species (ROS) (30) and interfere with glutathione reductase and superoxide
dismutase (31). However, after the ﬁrst dose of ISO, the heart showed decreased lipid
peroxidation. This is because the initial hypertrophy of the heart can protect itself to a limited
extent against oxidative stress. The second dose of ISO, administered 24 h after the ﬁrst
treatment, showed toxic effects resulting in a higher increase in lipid peroxidation (30).
Pretreatment with cerebrolysin decreased the levels of lipid peroxidation in terms of
TBARs while it increased the level of SOD in the heart of ISO-induced cardiotoxic rats when
compared to non-treated ischemic group. The previous study had shown that cerebrolysin
already decreased the TBARs’ levels in the brain (14, 40) and heart tissue (29) with their
resulting consequences. Cerebrolysin induces a decrease in the serum SOD levels in rats with
































































Fig. 3. Effect of pretreatment of cerebrolysin (5 mL/kg) on the mean levels of cardiac p53. (A) Expression analysis of
p53 mRNA from cardiac tissues by RT-PCR. Lanes 2 and 3: ischemic cardiac tissues (gp III; ISO-treated group).
Lanes 4 and 5: cardiac tissues after treatment with cerebrolysin (gp IV; cerebrolysin-+ ISO-treated group). M=
100-bp DNA ladder. The upper 547-bp bands represent the ampliﬁcation of p53 in groups III and IV; and the lower
201-bp band represents the internal control GAPDH (Lane 1). (B) Quantitative analysis of p53 mRNA. Statistical
analysis was carried out by one-way ANOVA followed by Tukey’s HSD multiple comparison test. All values are
presented as means of six rats ± SEM. *Indicates signiﬁcant change from control values at p< 0.05. +Indicates
signiﬁcant change from cerebrolysin-treated groups at p< 0.05. $Indicates signiﬁcant change from ISO-treated
groups at p< 0.05
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brain injury (9). Deviatkina et al. (4) also reported the antioxidant effect of cerebrolysin in the
brain, liver, thymus, spleen, and serum of rats under acute stress conditions. This positive
antioxidant effect of cerebrolysin in the heart suggests its possible use in the experimental
treatment of heart disturbances (29).
In addition to necrosis, apoptosis also plays a role in the process of tissue damage after
MI. It is suggested that hypoxia-induced apoptosis has general molecular mediator, which is
p53 that may induce apoptosis by stimulating the expression of Bax and/or repression of
Bcl-2 expression (3, 16, 23). Being apoptotic markers, the increase in p53 expression and
decrease in Bcl-2 expression in the ISO-induced ischemic infarction group compared to the
control one shown in this study could be explained by hypoxia induced by ischemia. During
acute MI, the formation of ROS in infarction areas may exceed the anti-oxidative capacity to
initiate mitochondrial apoptotic signaling and activate Bax, a proapoptotic member of Bcl-2
family proteins (45). In healthy cells, the majority of Bax is localized in the cytosol, but with
initiation of apoptotic signaling, activated Bax rapidly translocates to the mitochondria and
undergoes a conformation shift to form protein-permeable pores on mitochondrial mem-
branes. This results in the release of proapoptotic factors and cytochrome c from the
mitochondria to the cytosol. Cytochrome c in turn forms apoptosomes, and activates
Caspase-3, leading to cell death. On the contrary, the overexpression of anti-apoptotic Bcl-



































































Fig. 4. Effect of pretreatment of cerebrolysin (5 mL/kg) on the mean levels of cardiac Bcl-2. (A) Expression analysis
of Bcl-2 mRNA from cardiac tissues by RT-PCR. Lanes 2 and 3: ischemic cardiac myocytes (gp III; ISO-treated
group). Lanes 4 and 5: cardiac tissues after treatment with cerebrolysin (gp IV; cerebrolysin-+ ISO-treated group).
M= 100-bp DNA ladder. The upper 201-bp band represents the internal control GAPDH (Lane 1) and the lower
174-bp bands represent the ampliﬁcation of Bcl-2 in groups III and IV. (B) Quantitative analysis of Bcl-2 mRNA.
Statistical analysis was carried out by one-way ANOVA followed by Tukey’s HSD multiple comparison test. All
values are presented as means of six rats ± SEM. *Indicates signiﬁcant change from control values at p< 0.05.
+Indicates signiﬁcant change from cerebrolysin-treated groups at p< 0.05. $Indicates signiﬁcant change from ISO-
treated groups at p< 0.05
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apoptotic signals and therefore it inhibits apoptosis (10). It has been already reported that
oxidative stress due to ISO administration provokes cardiac DNA fragmentation and apoptosis
(6). In addition, ROS-induced apoptosis in neonatal rat cardiomyocytes was associated with an
increase in p53 protein content, whereas protein concentrations of Bcl-2 and Bax were
unaltered (44). Furthermore, a natural antioxidant, Chinonin, signiﬁcantly attenuated
hypoxia-/reoxygenation-induced apoptosis, downregulated p53 expression, and induced
Bcl-2 upregulation (37). Inﬂammation has also been recognized as a major driving force in
the ischemic process with increasing incidence of inﬂammatory markers (8). TNF-α can also
induce cardiomyocyte apoptosis and participate in ventricular remodeling (49).
In contrast, it was found that ischemia-induced apoptosis occurred as readily in the p53
knockout mice as in wild-type mice indicating the existence of other, p53 independent,
mechanisms of post-ischemic apoptosis (2). This may involve the stress-activated protein
kinase (SAPK) signaling pathway as an important mediator of apoptosis where its activity is
dramatically increased in rabbit hearts after ischemia/reperfusion (48).
Cerebrolysin restored the p53/Bcl-2 balance, thus providing an anti-apoptosis effect
against MI damage in this study. These results are in line with Formichi et al., (5) who
recorded a protective effect of cerebrolysin on oxidative stress-induced apoptosis in
peripheral blood lymphocytes. Also, cerebrolysin markedly caused downregulation of
Bcl-2 and upregulation of Bax in the ipsilateral thalamus after cerebral infarction in rats (47).
This study demonstrated that ISO-induced rats showed increase in myocardial infarct
size with less TTC absorbing capacity. The induction of MI by ISO was previously reported
by Li et al. (17). TTC dye forms a red formazan precipitate in the presence of intact lactate
dehydrogenase enzyme activity, while the infarcted myocardium in lack of this dehydroge-
nase system fails to be stained with it. Unstained area of infarction had leakage of
dehydrogenases and loss of membrane integrity (28). Pretreatment with cerebrolysin
signiﬁcantly decreased the infarction size which might be due to its potent antioxidant and
anti-apoptotic activity that prevents cell death and leakage of lactate dehydrogenase enzymes.
Conclusion
Cerebrolysin could protect rat myocardium against ischemic insult through attenuation of
oxidative stress-induced apoptosis, and thereby cerebrolysin could have a future recommen-
dation in the prevention and/or treatment of ischemic heart diseases.
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